期刊文献+

MEF2A RNA干扰对小鼠主动脉内皮细胞MEF2A表达及细胞间黏附分子-1、血管细胞黏附分子-1表达的影响 被引量:3

Effects of RNA interference of myocyte enhancer factor 2A on expressions of MEF2A,ICAM-1,and VCAM-1 in mice aortic endothelial cells
下载PDF
导出
摘要 目的:观察肌细胞增强因子2A(MEF2A)RNA干扰对小鼠主动脉内皮细胞MEF2A及细胞间黏附分子-1(ICAM-1)、血管细胞黏附分子-1(VCAM-1)表达的影响。方法:培养小鼠主动脉内皮细胞,构建MEF2A RNA干扰慢病毒或者阴性对照慢病毒(NC)并转染小鼠主动脉内皮细胞。实验设对照组(不加慢病毒)、NC组和MEF2A RNA干扰组3组,应用ELISA和RT-PCR法分别检测MEF2A及ICAM-1、VCAM-1蛋白及mRNA的表达水平。结果:ICAM-1在对照组、NC组和MEF2A RNA干扰组上清液中的表达量分别为(1.133±0.182)、(1.267±0.115)、(2.249±0.185)μg/L;VCAM-1在对照组、NC组和MEF2A RNA干扰组上清液中的表达量分别为(2.382±0.204)、(2.253±0.281)、(5.077±0.198)μg/L。ICAM-1、VCAM-1在上清液中的水平及mRNA表达水平,NC组与对照组相比,差异无统计学意义(P>0.05);MEF2A RNA干扰组与对照组和NC组相比均升高(P<0.05)。结论:慢病毒介导的MEF2A RNA干扰可抑制小鼠主动脉内皮细胞MEF2A活性及mRNA的表达,并可促进血管内ICAM-1、VCAM-1蛋白及mRNA的表达。 Aim: To identify the effects of RNA interference of myocyte enhancer factor 2A( MEF2A) on the expressions of MEF2 A and relative inflammatory genes ICAM-1 and VCAM-1 in mice aortic endothelial cells. Methods: The aortic endothelial cells in mice were cultivated,then MEF2 A lentivirus RNA interference or negative control lentivirus( NC)were built and transfected aortic endothelial cells in mice. The cells were allocated into control group( without lentivirus),NC group,and MEF2 A RNA interference group. MEF2 A,ICAM-1,and VCAM-1 expressions were detected by ELISA,and mRNA levels of MEF2 A,ICAM-1,and VCAM-1 were further examined by RT-PCR. Results: In the control group,NC group,and MEF2 A RNA interference group,ICAM-1 expression in the supernatant fluid were( 1. 133 ± 0. 182),( 1. 267 ± 0. 115),and( 2. 249 ± 0. 185) μg/L,VCAM-1 expression in the supernatant fluid were( 2. 382 ± 0. 204),( 2. 253 ± 0. 281),and( 5. 077 ± 0. 198) μg/L. There was no significant difference in ICAM-1 or VCAM-1 expression in the supernatant fluid between NC group and the control group( P 0. 05). When MEF2 A RNA interference group was compared with the control group and NC group,there were significant differences( P 0. 05). Conclusion: Lentivirus-mediated RNA interference of MEF2 A could inhibit the expression of MEF2 A and promote intravascular ICAM-1,VCAM-1 activity mRNA expression.
出处 《郑州大学学报(医学版)》 CAS 北大核心 2016年第4期502-505,共4页 Journal of Zhengzhou University(Medical Sciences)
基金 河南省高校科技创新团队基金资助项目14IRTSTHN018
关键词 小鼠 肌细胞增强因子2A RNA干扰 ICAM-1 VCAM-1 mouse myocyte enhancer factor 2A RNA interference ICAM-1 VCAM-1
  • 相关文献

参考文献2

二级参考文献45

  • 1崔斌,黄岚,周音频,武晓静,于世勇.大鼠脾源性内皮祖细胞移植在损伤血管内膜修复中的作用[J].第三军医大学学报,2006,28(15):1553-1556. 被引量:3
  • 2蔡雪黎,肖方毅,张怀勤,黄伟剑,林以诺,周浩,林杰,杨德业.另一类型内皮祖细胞移植在损伤血管内膜修复中的作用[J].吉林大学学报(医学版),2007,33(4):662-666. 被引量:3
  • 3Burke JE, Dennis EA. Phospholipase A2 biochemistry. Cardiovasc Drugs Ther 2009; 23: 49-59.
  • 4Prescott SM, Zimmerman GA, Stafforini DM, Mclntyre TM. Platelet- activating factor and related lipid mediators. Annu Rev Biochem 2000; 69: 419-45.
  • 5Stafforini DM. Biology of platelet activating factor acetyhydrolase (PAF-AH, lipoprotein associated phospholipase A2). Cardiovasc Drugs Ther 2009; 23: 73-83.
  • 6Kasperska-Zajac A, Brzoza Z, Rogala B. Platelet-activating factor (PAF): a review of its role in asthma and clinical efficacy of PAF antagonists in the disease therapy. Recent Pat Inflamm Allergy Drug Discov 2008; 2: 72-6.
  • 7Miller RG, Costacou T, Orchard TJ. Lipoprotein-associated phos- pholipase A2, C-reactive protein, and coronary artery disease in individuals with type 1 diabetes and macroalbuminuria. Diab Vasc Dis Res 2010; 7: 47-55.
  • 8Wegner M, Araszkiewicz A, Piorunska-Mikolajczak A, Zozulinska- Ziolkiewicz D, Wierusz-Wysocka B, Piorunska-Stolzmann M. Theevaluation of 11_-12 concentration, PAF-AH, and PLA(2) activity in patients with type 1 diabetes treated with intensive insulin therapy. Clin Biochem 2009; 42: 1621-7.
  • 9Zalewski A, Macphee C. Role of lipoprotein-associated phospholipase A2 in atherosclerosis: biology, epidemiology, and possible therapeutic target. Arterioscler Thromb Vasc Bio12005; 25: 923-31.
  • 10Wang WY, Li J, Yang D, Xu W, Zha RP, Wang YP. OxLDL stimulates lipo- protein-associated phospholipase A2 expression in THP-1 monocytes via PI3K and p38 MAPK pathways. Cardiovasc Res 2010; 85: 845- 52.

共引文献20

同被引文献17

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部